Skip to main content
Premium Trial:

Request an Annual Quote

Anagnostics Using Scienion Technology for Sepsis Test Products

NEW YORK (GenomeWeb News) – Scienion and Anagnostics Bioanalysis today said that Anagnostics is using Scienion's SciFlexArrayer in the production of Anagnostics' new products focused on integrating sepsis testing.

Anagnostics, based in St. Valentin, Austria, develops systems and tests for multiplex diagnostics. Its hybcell technology is a microarray based on cylinders instead of slides. Hybcells are automatically processed by the company's fully integrated and automated single device system for multiplexed diagnostics called hyborgs.

"The SciFlexArrayer proved to be the best dispensing device to print our hybcells, be it for DNA- or protein-based tests," Anagnostics CEO Christoph Reschreiter said in a statement. "We produce ready-to-use microarrays for our customers and precision and reproducibility have been key criteria when we have decided to work with this Scienion dispenser."

In July, the company inked a deal with Molzym to develop hybcell Pathogens DNA, a system for the rapid identification of sepsis-causing pathogens from whole blood.

Scienion has offices in Berlin and Dortmund, Germany and a US subsidiary in Princeton, NJ, and provides systems and services for contact-free printing of biological and chemical agents. Its SciFlexArrayers are automated non-contact dispensing systems for ultra-low volume liquid handling of biological samples.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.